The global market for Anti-Malarial Drug was valued at US$ 718 million in the year 2024 and is projected to reach a revised size of US$ 857 million by 2031, growing at a CAGR of 2.6% during the forecast period.

Anti-Malarial Drug Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Malarial Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Malarial Drug.

The Anti-Malarial Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Malarial Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Malarial Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-Malarial Drug Market Report

Report Metric	Details
Report Name	Anti-Malarial Drug Market
Accounted market size in year	US$ 718 million
Forecasted market size in 2031	US$ 857 million
CAGR	2.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Plasmodium Falciparum Plasmodium Vivax Plasmodium Malariae Plasmodium Ovale
Segment by Application	Hospital Pharmacy Retail Pharmacy E-Commerce Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Ranbaxy, Zydus Cadila, Alvizia, Bayer, Ipca, Merck, F. Hoffmann-La Roche, Novartis, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Malarial Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-Malarial Drug Market growing?

Ans: The Anti-Malarial Drug Market witnessing a CAGR of 2.6% during the forecast period 2025-2031.

What is the Anti-Malarial Drug Market size in 2031?

Ans: The Anti-Malarial Drug Market size in 2031 will be US$ 857 million.

Who are the main players in the Anti-Malarial Drug Market report?

Ans: The main players in the Anti-Malarial Drug Market are GlaxoSmithKline, Ranbaxy, Zydus Cadila, Alvizia, Bayer, Ipca, Merck, F. Hoffmann-La Roche, Novartis, Pfizer

What are the Application segmentation covered in the Anti-Malarial Drug Market report?

Ans: The Applications covered in the Anti-Malarial Drug Market report are Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others

What are the Type segmentation covered in the Anti-Malarial Drug Market report?

Ans: The Types covered in the Anti-Malarial Drug Market report are Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale

1 Anti-Malarial Drug Market Overview

1.1 Product Definition

1.2 Anti-Malarial Drug by Type

1.2.1 Global Anti-Malarial Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Plasmodium Falciparum

1.2.3 Plasmodium Vivax

1.2.4 Plasmodium Malariae

1.2.5 Plasmodium Ovale

1.3 Anti-Malarial Drug by Application

1.3.1 Global Anti-Malarial Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 E-Commerce

1.3.5 Others

1.4 Global Anti-Malarial Drug Market Size Estimates and Forecasts

1.4.1 Global Anti-Malarial Drug Revenue 2020-2031

1.4.2 Global Anti-Malarial Drug Sales 2020-2031

1.4.3 Global Anti-Malarial Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Anti-Malarial Drug Market Competition by Manufacturers

2.1 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Anti-Malarial Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Anti-Malarial Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Anti-Malarial Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anti-Malarial Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anti-Malarial Drug, Product Type & Application

2.7 Global Key Manufacturers of Anti-Malarial Drug, Date of Enter into This Industry

2.8 Global Anti-Malarial Drug Market Competitive Situation and Trends

2.8.1 Global Anti-Malarial Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anti-Malarial Drug Players Market Share by Revenue

2.8.3 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anti-Malarial Drug Market Scenario by Region

3.1 Global Anti-Malarial Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Anti-Malarial Drug Sales by Region: 2020-2031

3.2.1 Global Anti-Malarial Drug Sales by Region: 2020-2025

3.2.2 Global Anti-Malarial Drug Sales by Region: 2026-2031

3.3 Global Anti-Malarial Drug Revenue by Region: 2020-2031

3.3.1 Global Anti-Malarial Drug Revenue by Region: 2020-2025

3.3.2 Global Anti-Malarial Drug Revenue by Region: 2026-2031

3.4 North America Anti-Malarial Drug Market Facts & Figures by Country

3.4.1 North America Anti-Malarial Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Anti-Malarial Drug Sales by Country (2020-2031)

3.4.3 North America Anti-Malarial Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Anti-Malarial Drug Market Facts & Figures by Country

3.5.1 Europe Anti-Malarial Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Anti-Malarial Drug Sales by Country (2020-2031)

3.5.3 Europe Anti-Malarial Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anti-Malarial Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Anti-Malarial Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Anti-Malarial Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Anti-Malarial Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Anti-Malarial Drug Market Facts & Figures by Country

3.7.1 Latin America Anti-Malarial Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Anti-Malarial Drug Sales by Country (2020-2031)

3.7.3 Latin America Anti-Malarial Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anti-Malarial Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Anti-Malarial Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Anti-Malarial Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Anti-Malarial Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Anti-Malarial Drug Sales by Type (2020-2031)

4.1.1 Global Anti-Malarial Drug Sales by Type (2020-2025)

4.1.2 Global Anti-Malarial Drug Sales by Type (2026-2031)

4.1.3 Global Anti-Malarial Drug Sales Market Share by Type (2020-2031)

4.2 Global Anti-Malarial Drug Revenue by Type (2020-2031)

4.2.1 Global Anti-Malarial Drug Revenue by Type (2020-2025)

4.2.2 Global Anti-Malarial Drug Revenue by Type (2026-2031)

4.2.3 Global Anti-Malarial Drug Revenue Market Share by Type (2020-2031)

4.3 Global Anti-Malarial Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Anti-Malarial Drug Sales by Application (2020-2031)

5.1.1 Global Anti-Malarial Drug Sales by Application (2020-2025)

5.1.2 Global Anti-Malarial Drug Sales by Application (2026-2031)

5.1.3 Global Anti-Malarial Drug Sales Market Share by Application (2020-2031)

5.2 Global Anti-Malarial Drug Revenue by Application (2020-2031)

5.2.1 Global Anti-Malarial Drug Revenue by Application (2020-2025)

5.2.2 Global Anti-Malarial Drug Revenue by Application (2026-2031)

5.2.3 Global Anti-Malarial Drug Revenue Market Share by Application (2020-2031)

5.3 Global Anti-Malarial Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Company Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GlaxoSmithKline Anti-Malarial Drug Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Ranbaxy

6.2.1 Ranbaxy Company Information

6.2.2 Ranbaxy Description and Business Overview

6.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Ranbaxy Anti-Malarial Drug Product Portfolio

6.2.5 Ranbaxy Recent Developments/Updates

6.3 Zydus Cadila

6.3.1 Zydus Cadila Company Information

6.3.2 Zydus Cadila Description and Business Overview

6.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Zydus Cadila Anti-Malarial Drug Product Portfolio

6.3.5 Zydus Cadila Recent Developments/Updates

6.4 Alvizia

6.4.1 Alvizia Company Information

6.4.2 Alvizia Description and Business Overview

6.4.3 Alvizia Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Alvizia Anti-Malarial Drug Product Portfolio

6.4.5 Alvizia Recent Developments/Updates

6.5 Bayer

6.5.1 Bayer Company Information

6.5.2 Bayer Description and Business Overview

6.5.3 Bayer Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Bayer Anti-Malarial Drug Product Portfolio

6.5.5 Bayer Recent Developments/Updates

6.6 Ipca

6.6.1 Ipca Company Information

6.6.2 Ipca Description and Business Overview

6.6.3 Ipca Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Ipca Anti-Malarial Drug Product Portfolio

6.6.5 Ipca Recent Developments/Updates

6.7 Merck

6.7.1 Merck Company Information

6.7.2 Merck Description and Business Overview

6.7.3 Merck Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck Anti-Malarial Drug Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 F. Hoffmann-La Roche

6.8.1 F. Hoffmann-La Roche Company Information

6.8.2 F. Hoffmann-La Roche Description and Business Overview

6.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio

6.8.5 F. Hoffmann-La Roche Recent Developments/Updates

6.9 Novartis

6.9.1 Novartis Company Information

6.9.2 Novartis Description and Business Overview

6.9.3 Novartis Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Novartis Anti-Malarial Drug Product Portfolio

6.9.5 Novartis Recent Developments/Updates

6.10 Pfizer

6.10.1 Pfizer Company Information

6.10.2 Pfizer Description and Business Overview

6.10.3 Pfizer Anti-Malarial Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Pfizer Anti-Malarial Drug Product Portfolio

6.10.5 Pfizer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anti-Malarial Drug Industry Chain Analysis

7.2 Anti-Malarial Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anti-Malarial Drug Production Mode & Process Analysis

7.4 Anti-Malarial Drug Sales and Marketing

7.4.1 Anti-Malarial Drug Sales Channels

7.4.2 Anti-Malarial Drug Distributors

7.5 Anti-Malarial Drug Customer Analysis

8 Anti-Malarial Drug Market Dynamics

8.1 Anti-Malarial Drug Industry Trends

8.2 Anti-Malarial Drug Market Drivers

8.3 Anti-Malarial Drug Market Challenges

8.4 Anti-Malarial Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Anti-Malarial Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Anti-Malarial Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Anti-Malarial Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Anti-Malarial Drug Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Anti-Malarial Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Anti-Malarial Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Anti-Malarial Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Anti-Malarial Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Anti-Malarial Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anti-Malarial Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anti-Malarial Drug, Product Type & Application

Table 12. Global Key Manufacturers of Anti-Malarial Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Malarial Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-Malarial Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Anti-Malarial Drug Sales by Region (2020-2025) & (Units)

Table 18. Global Anti-Malarial Drug Sales Market Share by Region (2020-2025)

Table 19. Global Anti-Malarial Drug Sales by Region (2026-2031) & (Units)

Table 20. Global Anti-Malarial Drug Sales Market Share by Region (2026-2031)

Table 21. Global Anti-Malarial Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Anti-Malarial Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Anti-Malarial Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Anti-Malarial Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Anti-Malarial Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Anti-Malarial Drug Sales by Country (2020-2025) & (Units)

Table 27. North America Anti-Malarial Drug Sales by Country (2026-2031) & (Units)

Table 28. North America Anti-Malarial Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Anti-Malarial Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Anti-Malarial Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Anti-Malarial Drug Sales by Country (2020-2025) & (Units)

Table 32. Europe Anti-Malarial Drug Sales by Country (2026-2031) & (Units)

Table 33. Europe Anti-Malarial Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Anti-Malarial Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Anti-Malarial Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Anti-Malarial Drug Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Anti-Malarial Drug Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Anti-Malarial Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Anti-Malarial Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Anti-Malarial Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Anti-Malarial Drug Sales by Country (2020-2025) & (Units)

Table 42. Latin America Anti-Malarial Drug Sales by Country (2026-2031) & (Units)

Table 43. Latin America Anti-Malarial Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Anti-Malarial Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Anti-Malarial Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Anti-Malarial Drug Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Anti-Malarial Drug Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Anti-Malarial Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Anti-Malarial Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Anti-Malarial Drug Sales (Units) by Type (2020-2025)

Table 51. Global Anti-Malarial Drug Sales (Units) by Type (2026-2031)

Table 52. Global Anti-Malarial Drug Sales Market Share by Type (2020-2025)

Table 53. Global Anti-Malarial Drug Sales Market Share by Type (2026-2031)

Table 54. Global Anti-Malarial Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Anti-Malarial Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Anti-Malarial Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Anti-Malarial Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Anti-Malarial Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Anti-Malarial Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Anti-Malarial Drug Sales (Units) by Application (2020-2025)

Table 61. Global Anti-Malarial Drug Sales (Units) by Application (2026-2031)

Table 62. Global Anti-Malarial Drug Sales Market Share by Application (2020-2025)

Table 63. Global Anti-Malarial Drug Sales Market Share by Application (2026-2031)

Table 64. Global Anti-Malarial Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Anti-Malarial Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Anti-Malarial Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Anti-Malarial Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Anti-Malarial Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Anti-Malarial Drug Price (USD/Unit) by Application (2026-2031)

Table 70. GlaxoSmithKline Company Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. GlaxoSmithKline Anti-Malarial Drug Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Ranbaxy Company Information

Table 76. Ranbaxy Description and Business Overview

Table 77. Ranbaxy Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Ranbaxy Anti-Malarial Drug Product

Table 79. Ranbaxy Recent Developments/Updates

Table 80. Zydus Cadila Company Information

Table 81. Zydus Cadila Description and Business Overview

Table 82. Zydus Cadila Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Zydus Cadila Anti-Malarial Drug Product

Table 84. Zydus Cadila Recent Developments/Updates

Table 85. Alvizia Company Information

Table 86. Alvizia Description and Business Overview

Table 87. Alvizia Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Alvizia Anti-Malarial Drug Product

Table 89. Alvizia Recent Developments/Updates

Table 90. Bayer Company Information

Table 91. Bayer Description and Business Overview

Table 92. Bayer Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Bayer Anti-Malarial Drug Product

Table 94. Bayer Recent Developments/Updates

Table 95. Ipca Company Information

Table 96. Ipca Description and Business Overview

Table 97. Ipca Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Ipca Anti-Malarial Drug Product

Table 99. Ipca Recent Developments/Updates

Table 100. Merck Company Information

Table 101. Merck Description and Business Overview

Table 102. Merck Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Merck Anti-Malarial Drug Product

Table 104. Merck Recent Developments/Updates

Table 105. F. Hoffmann-La Roche Company Information

Table 106. F. Hoffmann-La Roche Description and Business Overview

Table 107. F. Hoffmann-La Roche Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. F. Hoffmann-La Roche Anti-Malarial Drug Product

Table 109. F. Hoffmann-La Roche Recent Developments/Updates

Table 110. Novartis Company Information

Table 111. Novartis Description and Business Overview

Table 112. Novartis Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Novartis Anti-Malarial Drug Product

Table 114. Novartis Recent Developments/Updates

Table 115. Pfizer Company Information

Table 116. Pfizer Description and Business Overview

Table 117. Pfizer Anti-Malarial Drug Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Pfizer Anti-Malarial Drug Product

Table 119. Pfizer Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Anti-Malarial Drug Distributors List

Table 123. Anti-Malarial Drug Customers List

Table 124. Anti-Malarial Drug Market Trends

Table 125. Anti-Malarial Drug Market Drivers

Table 126. Anti-Malarial Drug Market Challenges

Table 127. Anti-Malarial Drug Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anti-Malarial Drug

Figure 2. Global Anti-Malarial Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Anti-Malarial Drug Market Share by Type: 2024 & 2031

Figure 4. Plasmodium Falciparum Product Picture

Figure 5. Plasmodium Vivax Product Picture

Figure 6. Plasmodium Malariae Product Picture

Figure 7. Plasmodium Ovale Product Picture

Figure 8. Global Anti-Malarial Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Anti-Malarial Drug Market Share by Application: 2024 & 2031

Figure 10. Hospital Pharmacy

Figure 11. Retail Pharmacy

Figure 12. E-Commerce

Figure 13. Others

Figure 14. Global Anti-Malarial Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Anti-Malarial Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Anti-Malarial Drug Sales (2020-2031) & (Units)

Figure 17. Global Anti-Malarial Drug Average Price (USD/Unit) & (2020-2031)

Figure 18. Anti-Malarial Drug Report Years Considered

Figure 19. Anti-Malarial Drug Sales Share by Manufacturers in 2024

Figure 20. Global Anti-Malarial Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Anti-Malarial Drug Players: Market Share by Revenue in Anti-Malarial Drug in 2024

Figure 22. Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Anti-Malarial Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Anti-Malarial Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Anti-Malarial Drug Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Anti-Malarial Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Anti-Malarial Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Anti-Malarial Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Anti-Malarial Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Anti-Malarial Drug Sales Market Share by Country (2020-2031)

Figure 48. Latin America Anti-Malarial Drug Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Anti-Malarial Drug Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Anti-Malarial Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Anti-Malarial Drug by Type (2020-2031)

Figure 58. Global Revenue Market Share of Anti-Malarial Drug by Type (2020-2031)

Figure 59. Global Anti-Malarial Drug Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Anti-Malarial Drug by Application (2020-2031)

Figure 61. Global Revenue Market Share of Anti-Malarial Drug by Application (2020-2031)

Figure 62. Global Anti-Malarial Drug Price (USD/Unit) by Application (2020-2031)

Figure 63. Anti-Malarial Drug Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions